IMVT - Immunovant Inc
IEX Last Trade
30.93
-0.050 -0.162%
Share volume: 658,055
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$30.98
-0.05
-0.16%
Summary score
25%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over timeo
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over timeo
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over time
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMVT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.1% | 3.38% | 10.1% | 6.09% |
| Return on assets | -6.9% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | 76.8% | 4.88% | 8.3% | 11.96% |
| Profitability | 25% | 47% | 69% | 63% |
| Total debt ratio | 11.65% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | 0% | 14.95% | 5.12% | 1.7% |
| Dept financing | 3% | 50% | 26% | 10% |
| Current Ratio | 8.58% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 8.37% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 15% | 38% | 36% |
| Short-term ratios | IMVT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.1% | -24.18% | 18.55% | 5.09% |
| Return on assets | -6.9% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | 76.8% | 7.93% | 10.38% | 10.86% |
| Profitability | 25% | 50% | 73% | 48% |
| Total debt ratio | 11.65% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | 0% | 16.62% | 5.88% | 2.04% |
| Dept financing | 3% | 50% | 27% | 9% |
| Current Ratio | 8.58% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 8.37% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 18% | 26% | 42% |